StonvexLoading…
StonvexCore line items from MATV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $518.67M | $479.60M | $1.99B | $1.52B | $1.01B |
Operating Income | Not available | $7.30M | $-384.40M | $-394.50M | $-410.50M |
Net Income | Not available | $-11.70M | $-337.40M | $-438.20M | $-435.00M |
EPS (Diluted) | $0.29 | $-0.22 | $-6.19 | $-8.04 | $-7.98 |
Total Assets | Not available | $2.03B | $2.05B | $2.00B | $2.08B |
Total Liabilities | Not available | $1.56B | $1.55B | $1.60B | $1.66B |
Cash & Equivalents | Not available | $82.30M | $84.20M | $97.10M | $95.60M |
Free Cash Flow OCF − CapEx | Not available | $-7.40M | $93.80M | $85.80M | $19.10M |
Shares Outstanding | Not available | 55.11M | 54.68M | 54.68M | 54.65M |